Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001509859 | SCV001716758 | benign | not provided | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001509859 | SCV003798511 | uncertain significance | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV003405695 | SCV004114215 | uncertain significance | CARMIL2-related disorder | 2023-05-30 | criteria provided, single submitter | clinical testing | The CARMIL2 c.3554A>C variant is predicted to result in the amino acid substitution p.Glu1185Ala. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.36% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-67688567-A-C), which may be too common to be causative of disease. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Breakthrough Genomics, |
RCV001509859 | SCV005249150 | benign | not provided | criteria provided, single submitter | not provided |